Cargando…
Effect of combining anticoagulant and glucocorticoid therapy on mortality in patients with severe COVID-19
INTRODUCTION: Coronavirus disease (COVID-19) has spread rapidly to more than 200 countries and regions worldwide. Although several options have been implemented in attempts to control the rate of COVID-19 infection, the mortality rates remain high. The aim of this study is to evaluate whether patien...
Autores principales: | Shi, Can, Wu, Tian, Hu, Jing, Guo, Ren, Liu, Zuoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361025/ http://dx.doi.org/10.1177/1721727X221100942 |
Ejemplares similares
-
Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy
por: Cho, Eun-Hee
Publicado: (2023) -
Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study
por: Li, Yuping, et al.
Publicado: (2021) -
The effect of glucocorticoids on mortality in severe COVID-19 patients: Evidence from 13 studies involving 6612 cases
por: Yu, Guang-Qing, et al.
Publicado: (2021) -
Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis
por: Li, Yiwei, et al.
Publicado: (2020) -
Tailoring glucocorticoids in patients with severe COVID-19: a narrative review
por: Luo, Ming-Hao, et al.
Publicado: (2021)